Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a...

Por Laura L Hammitt, John Ojal, Mahfudh Bashraheil, Susan C Morpeth, Angela Karani, Ahsan Habib, Dorota Borys, David Goldblatt, J Anthony G Scott
Publicado em 2014-01-01

Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya

Por Stefan Flasche, John Ojal, Olivier Le Polain de Waroux, Mark Otiende, Katherine L. O’Brien, Moses Kiti, D. James Nokes, W John Edmunds, J. Anthony G. Scott
Publicado em 2017-06-01

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya

Por John Ojal, PhD, Ulla Griffiths, PhD, Laura L Hammitt, MD, Ifedayo Adetifa, PhD, Donald Akech, BSc, Collins Tabu, PhD, J Anthony G Scott, FRCP, Stefan Flasche, PhD
Publicado em 2019-05-01